meta_pixel
Tapesearch Logo
Log in
The John Batchelor Show

#Bestof2022: Tomorrow's: Brave New World of hallucinogens as remedy for the brain. Natasha Loder, Economist. (Originally posted October 16, 2022)

The John Batchelor Show

John Batchelor

Society & Culture, Arts, News, Books

4.52.8K Ratings

🗓️ 28 March 2023

⏱️ 11 minutes

🧾️ Download transcript

Summary

Photo: No known restrictions on publication.
@Batchelorshow



#Bestof2022: Tomorrow's: Brave New World of hallucinogens as remedy for the brain. Natasha Loder, Economist. (Originally posted October 16, 2022)


https://www.economist.com/technology-quarterly/2022/09/21/ketamine-psilocybin-and-ecstasy-are-coming-to-the-medicine-cabinet

Transcript

Click on a timestamp to play from that location

0:00.0

This is CBS I In The World. I'm John Bachelor.

0:08.0

Illusionogenics, my childhood included hallucinogenics, especially the famous LSD being celebrated

0:16.0

in rock festivals, notably at the Woodstock Festival. However, all these decades later, I learned

0:23.0

from Natasha Loder, the health policy editor of the economists. What I understood to be hallucinogenics

0:30.3

are part of a large library now of investigations of the applications of psychodelic or psychohalucin

0:42.2

psychotherapeutic drugs and manufacturing of these events in order to cure or at least disrupt

0:51.0

depression, addiction, PTSD and anxiety. Natasha, a very good evening to you. Thank you very much

0:59.0

for this. First, I see the mission in front of us and I go immediately to something I didn't know until

1:06.0

you revealed it in your article. The FDA has already approved something along these lines called

1:11.4

ketamine. What is its intention? Good evening to you. Hello. So the intention of ketamine or S

1:18.8

ketamine, better known as bravato, is to relieve treatment resistant depression and what that means

1:26.2

is depression that has been treated by a whole bunch of other things including SSRIs and you failed

1:33.3

and you're kind of resistant to treatment. Well, you can now have this inhaled form of ketamine,

1:38.7

which is given under supervision, which is intended to provide some relief from the depression and

1:46.0

indeed, also. Relief, not cure relief. That's important to make this distinction because we now want to

1:53.7

look very carefully at what it might, what might be true of all these substances. I'll name them,

2:00.2

but they're very particular and clinically sounding, you know, HT5A. However, the brain is pictured

2:10.1

by Natasha's reporting as something like a tree. At one point, you use the metaphor of a rich canopy.

2:17.6

What is neural plasticity? What are dendrites in Natasha? So one of the underlying capabilities of

2:25.5

psychedelic drugs in the brain is that they seem to be able to introduce neural plasticity,

2:31.0

right? And that's physical changes in the growth of our neurons and the connection between them.

2:36.3

And they do it rapidly. And that's one of the features of ketamine is the relief is rapid. Now,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from John Batchelor, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of John Batchelor and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.